Emirates Drug Establishment Orders Recall of Additional Nestlé S26 AR Batches
The UAE’s Emirates Drug Establishment (EDE) has expanded a voluntary and precautionary recall of Nestlé infant formula to include additional batches of the product S26 AR, which is intended for use exclusively under medical supervision. The move was announced to safeguard public health and consumer safety, with the affected batch numbers identified as 5185080661, 5271080661, and 5125080661.
According to the EDE, the recall was initiated after traces of the bacterium Bacillus cereus were detected in a production input. The bacterium can produce cereulide toxin, which may lead to foodborne illness and gastrointestinal symptoms such as nausea, vomiting, and abdominal pain, prompting authorities to act as a precautionary measure.
In coordination with Nestlé, the EDE has secured all affected batches from distributor warehouses and is working to withdraw any remaining products from the market, including those sold through e-commerce platforms. The authority added that Nestlé MENA has issued a detailed public statement and introduced digital tools to help UAE consumers verify product batches and request refunds or replacements.
